NEJM - "A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management"

"A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management"

"CONCLUSIONS

In this study, 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control. (Funded by Novo Nordisk; SCALE Obesity and Prediabetes NN8022-1839 ClinicalTrials.gov number, NCT01272219.)"

http://www.nejm.org/doi/full/10.1056/NEJMoa1411892?query=featured_home